FDA Approves Sanofi's Nasacort Allergy 24HR Nasal Spray as OTC Treatment
October 11, 2013 at 14:32 PM EDT
Sanofi (NYSE: SNY ) announced today that the U.S. Food and Drug Administration (FDA) approved Nasacort® Allergy 24HR nasal spray as an over-the-counter (OTC) treatment for seasonal and year-round nasal allergies in adults and children 2 years of age and older. Nasacort is the first and only medicine in
